查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2000735

安全针市场：全球市场按产品类型、材料、分销管道、应用和最终用户分類的预测 - 2026-2032 年

Safety Needles Market by Product Type, Material, Distribution Channel, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，安全针市场价值将达到 66.7 亿美元，到 2026 年将成长至 72.5 亿美元，到 2032 年将达到 119.5 亿美元，复合年增长率为 8.67%。

主要市场统计数据
基准年 2025 66.7亿美元
预计年份：2026年 72.5亿美元
预测年份 2032 119.5亿美元
复合年增长率 (%) 8.67%

临床安全优先事项、监管期望和采购政策如何重塑安全针头的引进和策略采购，其根本背景为何？

安全针头产业处于病患安全、医疗服务流程和全球供应链韧性的关键交汇点。近年来，随着监管机构对预防事故的日益重视、门诊和居家照护场所的扩张，以及医护人员和患者安全期望的不断提高，安全针头已从一种小众的临床选择跃升为采购的核心优先事项。本文旨在探讨影响製造、分销和临床应用等各个环节采购行为、创新重点和竞争动态的根本因素。

临床使用者的需求、供应链韧性的压力以及产品创新如何从根本上改变安全针头的开发和采购？

安全针市场格局正经历一场变革，其驱动力来自临床、技术和供应方面的多重趋势。临床医师越来越重视人因工程和实证安全结果，单手操作、触觉回馈和稳定的防护性能等设计特性已成为关键的选择标准。同时，製造商也正在加速产品现代化，采用更简单的操作机制和材料，确保产品在各种医疗环境中都能可靠运作。

全面概述 2025 年美国关税调整将如何重塑整个价值链中的采购决策、製造地和相关人员成本趋势。

2025年美国关税政策的变化将对整个安全针俱生态系统中的相关人员产生连锁的营运和战略影响。对进口原材料、零件或成品征收关税将增加依赖进口的製造商和经销商的总进口成本，从而影响采购决策和合约谈判。对于拥有国际供应链的公司而言，重新评估供应商所在地和总到货成本迫在眉睫，这需要对关税风险、关税分类机会以及潜在的风险缓解措施（例如关税工程和替代原材料）进行更详细的分析。

基于细分的详细洞察，揭示产品类型、材料、应用、最终用户和分销管道如何相互作用并影响采用和采购结果。

本市场分析依产品类型将产品分为两大类：「主动式」和「被动式」。每类产品都有其独特的运作机制和使用者互动方式，这会影响其临床应用模式。同时，根据材料成分，市场又分为「金属」和「塑胶」两类。材料的选择会影响产品的耐用性、灭菌相容性、製造成本结构和可回收性，而这些因素在采购评估中变得越来越重要。

一份策略性区域分析报告，阐述了美洲、欧洲、中东和非洲以及亚太市场的监管、采购和采用驱动因素有何不同。

区域趋势在塑造安全针头市场的监管预期、采购行为和创新应用方面发挥着至关重要的作用。在美洲，医疗保健系统拥有完善的组织采购架构和强有力的临床管治，优先采购那些具有明确且可证实的安全优势并符合感染预防方案的医疗器材。采购週期会受到公共卫生倡议和支付方审查的影响，供应商通常需要提供可靠的临床数据才能获得大规模机构合约。

对决定安全针创新和供应可靠性主导主要企业的竞争动态、战略伙伴关係和能力优先事项进行了深入分析。

安全针头产业的竞争动态凸显了产品持续改进、合规性和一体化服务的重要性。市场参与企业优先投资于人因工程测试和临床证据的积累，以在采购过程中脱颖而出，因为可验证的结果和安全性声明备受重视。製造商与临床合作伙伴之间的合作日益加强，共同开发先导计画和真实世界证据研究有助于加快产品在临床相关人员中的接受度。

为製造商、经销商和采购经理提供切实可行的高优先级建议，以加快安全针头产业的采用、降低风险并增强竞争优势。

产业领导者应采取多管齐下的策略方法，将产品开发、供应链韧性和商业性合作结合，以掌握新的机会。首先，在开发週期的早期阶段，应优先考虑人体工学和严格的临床检验，以开发出既能切实降低针刺风险，又能方便各类使用者使用的设备。投资临床研究和真实世界证据将显着加强采购对话，并加速医疗机构和社区对相关产品的采用。

为了支持本报告的发现和结论，我们将详细描述混合方法研究途径，该方法结合了初步访谈、文件分析和检验。

本调查方法结合一手和二手资料收集、结构化专家访谈以及交叉检验技术，确保获得可靠且可操作的见解。一手研究包括对临床医生、采购负责人和供应链高管的访谈，以收集关于医疗设备性能、采购标准和供应连续性挑战的第一手观点。这些定性资料用于产生假设，并制定有针对性的后续问题以检验新的主题。

简洁地总结了关键发现，这些发现将临床、供应链和商业性影响与相关人员联繫起来，以帮助他们了解不断变化的安全针头领域。

总之，安全针头的市场格局正受到临床优先事项、监管、不断变化的经销管道和供应链重组等因素的共同影响而重塑。随着医疗模式日益分散化和以患者为中心的医疗服务模式的扩展，那些兼具可靠安全机制、以用户为中心的设计以及经临床验证的疗效的医疗设备将获得采购和临床利益相关人员的鼎力支持。同时，关税调整和地缘政治发展等外部因素也在推动企业对製造地和筹资策略进行策略性重新评估。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：安全针市场：依产品类型划分

  • 活动类型
  • 被动的

第九章：安全针市场：依材料分类

  • 金属
  • 塑胶

第十章：安全针市场：依分销管道划分

  • 医院药房
  • 在线的
    • 企业网站
    • 第三方平台
  • 零售药房

第十一章 安全针市场：依应用领域划分

  • 血液样本
  • 胰岛素给药
  • 疫苗接种

第十二章：安全针市场：依最终用户划分

  • 诊所
  • 居家照护
  • 医院

第十三章：安全针市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：安全针市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 安全针市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国安全针市场

第十七章 中国安全针市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AdvaCare Pharma
  • Argon Medical Devices, Inc.
  • Artsana Group
  • B. Braun SE
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cartel Healthcare Pvt. Ltd.
  • Eli Lilly and Company
  • Gerresheimer AG
  • Hindustan Syringes and Medical Devices Ltd.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Nanchang Kindly（KDL）Medical Technology Co., Ltd.
  • Nipro Corporation
  • Novo Nordisk A/S
  • Retractable Technologies, Inc.
  • Retrago Technologies
  • Smiths Medical, Inc.
  • Socorex Isba SA
  • Sol-Millennium Medical Inc.
  • Terumo Europe NV
  • UltiMed, Inc.
Product Code: MRR-02026C4C9107

The Safety Needles Market was valued at USD 6.67 billion in 2025 and is projected to grow to USD 7.25 billion in 2026, with a CAGR of 8.67%, reaching USD 11.95 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.67 billion
Estimated Year [2026] USD 7.25 billion
Forecast Year [2032] USD 11.95 billion
CAGR (%) 8.67%

Foundational context on how clinical safety priorities, regulatory expectations, and procurement discipline are reshaping safety needle adoption and strategic sourcing

The safety needle sector occupies a critical intersection between patient safety, provider workflow, and global supply chain resilience. Over recent years, heightened regulatory attention on needlestick prevention, expanding outpatient and home-care settings, and rising expectations for clinician and patient safety have elevated safety needles from a niche clinical preference to a central procurement priority. This introduction establishes the contextual pillars that inform procurement behavior, innovation priorities, and competitive dynamics across manufacturing, distribution, and clinical adoption.

As stakeholders reevaluate product specifications and sourcing strategies, factors such as device ergonomics, activation reliability, and compatibility with existing clinical systems increasingly influence adoption decisions. Meanwhile, institutional purchasers and integrated delivery networks focus on lifecycle cost, staff training requirements, and post-market surveillance as part of broader patient-safety programs. At the same time, regulatory frameworks and guidance documents reinforce the need for demonstrable risk reduction and validated safety performance, prompting manufacturers to align development roadmaps with compliance pathways.

Taken together, these forces create a market environment where clinical evidence, supply continuity, and actionable total-cost perspectives determine which solutions gain traction. This introduction frames the rest of the executive summary by emphasizing how regulatory momentum, clinical priorities, and procurement discipline converge to shape near-term and medium-term choices for product development, sourcing, and distribution.

How converging clinical user needs, supply chain resilience pressures, and product innovation are driving fundamental changes in safety needle development and procurement

The landscape for safety needles is undergoing transformative shifts driven by converging clinical, technological, and supply-side dynamics. Clinicians are placing greater emphasis on human factors engineering and evidence-based safety outcomes, which has elevated design attributes such as single-handed activation, tactile feedback, and consistent shielding performance into primary selection criteria. At the same time, manufacturers are accelerating product modernization, integrating simpler activation mechanics and materials that support reliable function across varied care environments.

In parallel, care delivery is decentralizing; vaccination campaigns, chronic disease management, and insulin administration increasingly occur outside traditional inpatient settings. This transition amplifies demand for devices that are intuitive for non-clinician users, robust in home storage conditions, and compatible with community health workflows. Consequently, product roadmaps and marketing strategies have begun prioritizing usability testing with end users and expanded post-market data collection to demonstrate real-world safety benefits.

Supply chain pressure and procurement sophistication are catalyzing another wave of transformation. Buyers are seeking suppliers who can demonstrate not only product performance but also traceable manufacturing practices, resilient distribution channels, and responsive after-sales support. As a result, strategic partnerships, contract flexibility, and modular manufacturing approaches are becoming differentiators. Collectively, these shifts are redefining how value is created and measured across the safety needle ecosystem, moving the sector toward solutions that balance clinical efficacy, user-centered design, and operational resilience.

Comprehensive overview of how 2025 United States tariff adjustments are reshaping sourcing decisions, manufacturing footprints, and stakeholder cost dynamics across the value chain

United States tariff policy changes in 2025 have created a cascade of operational and strategic implications for stakeholders throughout the safety needle ecosystem. Tariffs on imported raw materials, component parts, or finished devices elevate landed costs for import-reliant manufacturers and distributors, which in turn influences sourcing decisions and contract negotiations. For companies with international supply chains, the need to reassess supplier footprints and total landed cost has become urgent, prompting deeper analysis of tariff exposure, tariff classification opportunities, and potential mitigation pathways such as tariff engineering or alternative inputs.

Moreover, tariffs can accelerate regionalization and nearshoring strategies. Firms that previously relied on low-cost overseas production may evaluate onshore or nearshore manufacturing alternatives to reduce tariff risk and improve supply continuity. While transition costs exist, organizations often find that improved lead times, lower inventory risk, and closer quality control offset near-term investment. Consequently, procurement teams are updating supplier scorecards to incorporate tariff sensitivity and geopolitical risk as explicit evaluative metrics.

Tariff changes also influence downstream stakeholders. Hospitals, clinics, and group purchasing organizations face revised procurement cycles as suppliers renegotiate pricing or revise contract terms. Payers and reimbursement entities may scrutinize cost increases and seek evidence that safety and quality benefits justify higher unit costs. Finally, regulatory compliance and customs classification accuracy have become higher priority activities, as incorrect classification can trigger retrospective duties or penalties. In response, cross-functional teams are strengthening collaboration among sourcing, legal, regulatory, and commercial functions to align mitigation strategies and maintain continuity of care delivery.

Deep segmentation-based insights revealing how product type, material, application, end user, and distribution channels converge to influence adoption and procurement outcomes

The market analysis segments product offerings by product type into two principal categories: Active and Passive devices, each with distinct activation mechanisms and user interaction profiles that influence clinical adoption patterns. In parallel, material composition divides the landscape into Metal and Plastic constructs, where material choice affects durability, sterilization compatibility, and manufacturing cost structures, as well as recyclability considerations that increasingly factor into procurement evaluations.

Application-focused segmentation highlights three core clinical uses: Blood Collection, Insulin Delivery, and Vaccination, each of which presents unique user requirements, throughput expectations, and regulatory considerations. Blood collection settings prioritize sample integrity and ease of phlebotomy workflows, insulin delivery emphasizes repeated home use and patient ergonomics, while vaccination campaigns demand high-volume deployment, ease of use by non-specialist staff, and storage robustness. End-user segmentation separates Clinics, Home Care, and Hospitals to reflect differing procurement processes, training intensity, and device lifecycle management needs. Devices destined for home care must balance simplicity and safety for lay users, whereas hospital procurement emphasizes integration with clinical systems and staff training.

Distribution channel segmentation spans Hospital Pharmacies, Online, and Retail Pharmacies, with Online further dissected into Company Websites and Third-Party Platforms to capture distinct buyer journeys and fulfillment arrangements. These distribution pathways shape time-to-market, pricing transparency, and after-sales support expectations. Understanding how these segmentation dimensions intersect enables clearer targeting and product positioning, revealing where clinical benefits, operational fit, and commercial viability converge to drive adoption.

Strategic regional analysis that explains how Americas, Europe Middle East & Africa, and Asia-Pacific markets differ in regulation, procurement, and adoption drivers

Regional dynamics play a pivotal role in shaping regulatory expectations, procurement behavior, and innovation diffusion across the safety needle market. In the Americas, health systems exhibit strong institutional purchasing frameworks and a high level of clinical governance, which prioritize devices that deliver clear demonstrable safety advantages and align with infection prevention programs. Procurement cycles can be influenced by public health initiatives and payer scrutiny, and suppliers often need robust clinical data to secure large institutional contracts.

In Europe, Middle East & Africa, regulatory landscapes vary substantially, producing a patchwork of approval pathways and reimbursement models that require tailored market entry strategies. Countries with centralized procurement may generate rapid uptake for compliant products, yet differing national standards and economic contexts demand flexible pricing and distribution approaches. Meanwhile, emerging markets across the region present opportunities for scaled deployments of cost-effective safety solutions but necessitate attention to local supply chain constraints and training capabilities.

Asia-Pacific demonstrates diverse adoption vectors, where advanced markets show fast uptake of user-friendly, technologically sophisticated devices while many markets remain focused on affordability and supply continuity. Rapidly expanding outpatient care and vaccination programs in the region elevate demand for scalable, easily deployable solutions. Across all regions, geopolitical developments and trade policies influence manufacturing location decisions and inventory strategies, underlining the importance of localized distribution networks and partnerships to maintain continuity of care.

Insightful examination of competitive dynamics, strategic partnerships, and capability priorities that determine which companies lead in safety needle innovation and supply reliability

Competitive dynamics within the safety needle sector emphasize continuous product improvement, regulatory compliance, and integrated service offerings. Market participants prioritize investments in human factors testing and clinical evidence generation to substantiate safety claims and differentiate in procurement processes that reward demonstrable outcomes. Collaboration between manufacturers and clinical partners has intensified, with co-development pilots and real-world evidence studies helping to accelerate acceptance among clinician stakeholders.

Supply chain reliability and scale capabilities also shape competitive positioning. Firms that can demonstrate redundant production capacity, validated quality systems, and responsive distribution networks earn preference from large institutional buyers who prioritize uninterrupted supply. At the same time, smaller, more agile companies carve niches by introducing novel activation mechanisms or lower-cost designs tailored to specific applications or geographies. Strategic partnerships, licensing agreements, and targeted acquisitions are common avenues to acquire complementary technology, expand geographic reach, or bolster manufacturing capabilities.

Across the industry, commercialization strategies increasingly emphasize total cost of ownership narratives, training and implementation support, and lifecycle services such as sharps disposal programs. These value-added services help buyers manage operational transition risks and support sustained adoption. Given regulatory scrutiny and procurement sophistication, companies that integrate clinical validation, manufacturing robustness, and service-oriented offerings position themselves to compete successfully for institutional and community-based contracts.

Practical and prioritized recommendations for manufacturers, distributors, and procurement leaders to accelerate adoption, reduce risk, and strengthen competitive advantage in safety needles

Industry leaders should adopt a multi-pronged strategic approach that aligns product development, supply resilience, and commercial engagement to capture emerging opportunities. First, prioritize human factors engineering and rigorous clinical validation early in the development cycle to create devices that demonstrably reduce needlestick risk while remaining intuitive for varied user populations. Investing in clinical studies and real-world evidence will materially strengthen procurement conversations and facilitate uptake in both institutional and community settings.

Second, reassess supply chain design to mitigate tariff exposure and geopolitical risk by diversifying sourcing, exploring nearshoring opportunities, and establishing contingency capacity. Suppliers and buyers alike should incorporate tariff sensitivity and supplier continuity metrics into procurement evaluations and contract terms. Third, develop go-to-market strategies that tailor value propositions to distinct end users: emphasize ease of use and patient-support programs for home care, workflow integration and staff training for hospitals, and cost-effectiveness and scalability for large vaccination initiatives.

Finally, expand commercial models to include training services, implementation support, and lifecycle management offerings that reduce adoption friction. Collaborate proactively with regulatory and procurement stakeholders to streamline approval pathways and align product labeling with clinical evidence. By combining validated safety performance, resilient supply strategies, and compelling service bundles, leaders can accelerate adoption and build durable competitive advantage.

Thorough explanation of the mixed-methods research approach combining primary interviews, documentary analysis, and triangulation to underpin the report's findings and conclusions

The research methodology combines primary and secondary data collection, structured expert interviews, and cross-validation techniques to ensure robust and actionable insights. Primary research included interviews with clinicians, procurement officers, and supply chain executives to capture firsthand perspectives on device performance, procurement criteria, and supply continuity challenges. These qualitative inputs informed hypothesis generation and the development of targeted follow-up queries to validate emerging themes.

Secondary research drew on regulatory filings, guidance documents, clinical literature, and company disclosures to establish a factual baseline for device categories, material considerations, and application-specific requirements. Data triangulation techniques reconciled differences across sources to minimize bias and increase confidence in conclusions. Where applicable, case studies and product performance summaries supplemented interview findings to illustrate real-world adoption patterns and implementation considerations.

Analytical rigor was maintained through transparent documentation of data sources, interview protocols, and assumptions used in comparative analyses. Limitations were acknowledged where data granularity varied across regions or end-user segments, and sensitivity checks were performed to assess how alternate interpretations could influence strategic implications. This mixed-methods approach ensures practical relevance for decision-makers while preserving methodological integrity and reproducibility.

Concise synthesis of principal findings that ties together clinical, supply chain, and commercial implications for stakeholders navigating the evolving safety needle environment

In conclusion, the safety needle landscape is being reshaped by a confluence of clinical priorities, regulatory scrutiny, distribution evolution, and supply chain realignments. As care models decentralize and patient-centered delivery expands, devices that combine reliable safety activation, user-centered design, and proven clinical outcomes will garner the strongest support from procurement and clinical stakeholders. At the same time, external forces such as tariff adjustments and geopolitical dynamics are driving strategic reassessments of manufacturing footprints and sourcing strategies.

Organizations that proactively invest in validated safety performance, resilient supply networks, and service-oriented commercialization models will be best positioned to navigate near-term disruptions and capture long-term opportunities. Cross-functional collaboration across clinical, regulatory, sourcing, and commercial teams will be essential to translate product innovation into sustained adoption. Ultimately, the market will favor solutions that demonstrably reduce risk, integrate smoothly into care workflows, and provide predictable supply continuity for diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Safety Needles Market, by Product Type

  • 8.1. Active
  • 8.2. Passive

9. Safety Needles Market, by Material

  • 9.1. Metal
  • 9.2. Plastic

10. Safety Needles Market, by Distribution Channel

  • 10.1. Hospital Pharmacies
  • 10.2. Online
    • 10.2.1. Company Websites
    • 10.2.2. Third-Party Platforms
  • 10.3. Retail Pharmacies

11. Safety Needles Market, by Application

  • 11.1. Blood Collection
  • 11.2. Insulin Delivery
  • 11.3. Vaccination

12. Safety Needles Market, by End User

  • 12.1. Clinics
  • 12.2. Home Care
  • 12.3. Hospitals

13. Safety Needles Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Safety Needles Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Safety Needles Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Safety Needles Market

17. China Safety Needles Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AdvaCare Pharma
  • 18.6. Argon Medical Devices, Inc.
  • 18.7. Artsana Group
  • 18.8. B. Braun SE
  • 18.9. Becton, Dickinson and Company
  • 18.10. Boston Scientific Corporation
  • 18.11. Cardinal Health, Inc.
  • 18.12. Cartel Healthcare Pvt. Ltd.
  • 18.13. Eli Lilly and Company
  • 18.14. Gerresheimer AG
  • 18.15. Hindustan Syringes and Medical Devices Ltd.
  • 18.16. Medtronic PLC
  • 18.17. Merit Medical Systems, Inc.
  • 18.18. Nanchang Kindly(KDL) Medical Technology Co., Ltd.
  • 18.19. Nipro Corporation
  • 18.20. Novo Nordisk A/S
  • 18.21. Retractable Technologies, Inc.
  • 18.22. Retrago Technologies
  • 18.23. Smiths Medical, Inc.
  • 18.24. Socorex Isba SA
  • 18.25. Sol-Millennium Medical Inc.
  • 18.26. Terumo Europe NV
  • 18.27. UltiMed, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SAFETY NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SAFETY NEEDLES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SAFETY NEEDLES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SAFETY NEEDLES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SAFETY NEEDLES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SAFETY NEEDLES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES SAFETY NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA SAFETY NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SAFETY NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SAFETY NEEDLES MARKET SIZE, BY ACTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SAFETY NEEDLES MARKET SIZE, BY ACTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SAFETY NEEDLES MARKET SIZE, BY ACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SAFETY NEEDLES MARKET SIZE, BY PASSIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SAFETY NEEDLES MARKET SIZE, BY PASSIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SAFETY NEEDLES MARKET SIZE, BY PASSIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SAFETY NEEDLES MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SAFETY NEEDLES MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SAFETY NEEDLES MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SAFETY NEEDLES MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SAFETY NEEDLES MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SAFETY NEEDLES MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SAFETY NEEDLES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SAFETY NEEDLES MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SAFETY NEEDLES MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SAFETY NEEDLES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SAFETY NEEDLES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SAFETY NEEDLES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SAFETY NEEDLES MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SAFETY NEEDLES MARKET SIZE, BY COMPANY WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SAFETY NEEDLES MARKET SIZE, BY COMPANY WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SAFETY NEEDLES MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SAFETY NEEDLES MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SAFETY NEEDLES MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SAFETY NEEDLES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SAFETY NEEDLES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SAFETY NEEDLES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SAFETY NEEDLES MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SAFETY NEEDLES MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SAFETY NEEDLES MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SAFETY NEEDLES MARKET SIZE, BY INSULIN DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SAFETY NEEDLES MARKET SIZE, BY INSULIN DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SAFETY NEEDLES MARKET SIZE, BY INSULIN DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SAFETY NEEDLES MARKET SIZE, BY VACCINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SAFETY NEEDLES MARKET SIZE, BY VACCINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SAFETY NEEDLES MARKET SIZE, BY VACCINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SAFETY NEEDLES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SAFETY NEEDLES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SAFETY NEEDLES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SAFETY NEEDLES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SAFETY NEEDLES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SAFETY NEEDLES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SAFETY NEEDLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SAFETY NEEDLES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SAFETY NEEDLES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SAFETY NEEDLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS SAFETY NEEDLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA SAFETY NEEDLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SAFETY NEEDLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. GCC SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GCC SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. GCC SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. GCC SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. GCC SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 123. GCC SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. GCC SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. G7 SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. G7 SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. G7 SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. G7 SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. G7 SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 144. G7 SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. G7 SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. NATO SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. NATO SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. NATO SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. NATO SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. NATO SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 151. NATO SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. NATO SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL SAFETY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES SAFETY NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA SAFETY NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA SAFETY NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA SAFETY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA SAFETY NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA SAFETY NEEDLES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA SAFETY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA SAFETY NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)